Physician profile
Mara Gordon
NPI 1679399562
$1,171.36
in general payments reported to CMS, 2019-2025
12 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.36 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $409.56 | 2025 | |
| Ucb, INC. | $229.69 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $115.26 | 2025 | Dupixent |
| Amgen INC. | $89.96 | 2025 | Otezla |
| Sanofi-Aventis U.S. LLC | $85.00 | 2025 | |
| Abbvie INC. | $77.82 | 2025 | |
| Organon LLC | $53.23 | 2025 | |
| Botanix Sb INC | $34.31 | 2025 | Sofdra |
| Incyte Corporation | $24.55 | 2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $20.02 | 2025 | |
| Almirall LLC | $17.92 | 2025 | Seysara, Klisyri |
| Leo Pharma INC. | $14.04 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mara Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.